[Pancytopenic megaloblastic anaemia following administration of pyrimethamine, trimethoprim and sulphamethoxazole (author's transl)].
D000328:Adult; D000748:Anemia, Macrocytic / Q000139:chemically induced*; D000749:Anemia, Megaloblastic / Q000139:chemically induced*; D004357:Drug Synergism; D005493:Folic Acid Antagonists; D006801:Humans; D008297:Male; D011739:Pyrimethamine / Q000009:adverse effects*; D013420:Sulfamethoxazole / Q000009:adverse effects*; D014295:Trimethoprim / Q000009:adverse effects*
D005493:Folic Acid Antagonists; D014295:Trimethoprim; D013420:Sulfamethoxazole; D011739:Pyrimethamine
Anemia megaloblastica pancitopenica in corso di trattamento con pirimetamina, trimethoprim e sulfametossazolo